CLINICAL_TRIALS
trial_result
· 2017-05-17
Clinical Trial Update: Treatment With Namenda in Women at Risk for Cognitive Decline [NA]
Summary
Complete clinical trial evaluating memantine (Namenda) for women at risk of cognitive decline; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Dementia | NA | Status: COMPLETED | Results posted: 2017-05-17